XML 42 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2017   10,829,918    
Beginning balance at Dec. 31, 2017 $ 181,321 $ 61,855 $ 121,144 $ (1,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 17,173   17,173  
Net unrealized loss on securities available for sale, net of tax (6,232)     (6,232)
Net unrealized loss on cash flow hedging derivative instruments, net of tax 738     738
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax (20)     (20)
Comprehensive income 11,659   17,173 (5,514)
Cash dividends declared (8,902)   (8,902)  
Equity compensation expense 285 $ 285    
Payment to repurchase common stock (in shares)   (5,725)    
Payment to repurchase common stock (168)   (168)  
Issuance of restricted stock (in shares)   16,795    
Proceeds from sale of common stock (in shares)   16,128    
Proceeds from sale of common stock $ 466 $ 466    
Ending balance (in shares) at Sep. 30, 2018 10,857,116 10,857,116    
Ending balance at Sep. 30, 2018 $ 184,661 $ 62,606 129,247 (7,192)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,933      
Net unrealized loss on securities available for sale, net of tax (1,888)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ (5)      
Ending balance (in shares) at Sep. 30, 2018 10,857,116 10,857,116    
Ending balance at Sep. 30, 2018 $ 184,661 $ 62,606 129,247 (7,192)
Beginning balance (in shares) at Dec. 31, 2018 10,862,651 10,862,651    
Beginning balance at Dec. 31, 2018 $ 191,542 $ 62,855 132,460 (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 18,839   18,839  
Net unrealized loss on securities available for sale, net of tax 8,737     8,737
Net unrealized loss on cash flow hedging derivative instruments, net of tax (1,703)     (1,703)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 8     8
Comprehensive income 25,881   18,839 7,042
Cash dividends declared (9,694)   (9,694)  
Equity compensation expense 368 $ 368    
Payment to repurchase common stock (in shares)   (4,179)    
Payment to repurchase common stock (96)   (96)  
Issuance of restricted stock (in shares)   19,087    
Proceeds from sale of common stock (in shares)   18,772    
Proceeds from sale of common stock $ 488 $ 488    
Ending balance (in shares) at Sep. 30, 2019 10,896,331 10,896,331    
Ending balance at Sep. 30, 2019 $ 208,489 $ 63,711 141,509 3,269
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,288      
Net unrealized loss on securities available for sale, net of tax 936      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ 1      
Ending balance (in shares) at Sep. 30, 2019 10,896,331 10,896,331    
Ending balance at Sep. 30, 2019 $ 208,489 $ 63,711 $ 141,509 $ 3,269